![](https://medcitynews.com/wp-content/uploads/sites/7/2024/08/GettyImages-1683323085.jpg)
Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency
Patients with hypoparathyroidism have been clamoring for an alternative to a Takeda Pharmaceutical therapy set to cease production by the end of the year, leaving them with no drug treatments. FDA approval of an Ascendis Pharma drug finally gives them …